tilsotolimod Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 1 (1)

Interventional (1)

Gustave Roussy, Cancer Campus, Grand Paris (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadEGFR

I am/have/hadnon-small cell lung cancer

I am/have/hadcancer treatment

I am/have/hadmetastatic melanoma

I am/have/hadcancer therapy

I am/have/hadhcg pregnancy test

I am/have/hadadvanced cancer

I am/have/hadconventional treatment

I am/have/hadcolorectal cancer

I am/have/hadocular melanoma

I am/have/hadneutrophil count

I am/have/hadcancer

I am/have/hadendocrine disorder

I am/have/hadliver metastasis

I am/have/hadstage iv non-small cell lung cancer

I am/have/hadblood transfusion

I am/have/hadmeasurable disease

I am/have/hadmetastasis

I am/have/hadadvanced melanoma

I am/have/hadgilbert's syndrome

added new label for I am/have/had

more

I am looking for

I am looking formdx-ctla-4

I am looking fortilsotolimod

I am looking forbevacizumab

I am looking foripilimumab

I am looking fornivolumab

I am looking foroxaliplatin

I am looking forfluorouracil

I am looking formelanoma

I am looking fortumor markers

I am looking foririnotecan

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Intratumoral Tilsotolimod a TLR-9 Agonist Together With Intratumoral Ipilimumab and Intravenous Nivolumab in Patients With Advanced Cancers

Open label, phase Ib study of intratumoral tilsotolimod in combination with intratumoral ipilimumab and intravenous nivolumab. The trial will be divided into two parts: PART A: the first part will assess the safety of two regimen and will recruit patients with all types of injectable solid malignancies PART B: the …

non-small cell lung cancer

EGFR

cancer treatment

nivolumab

metastatic melanoma

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.